𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drugs acting on dopamine receptors: Usefulness of a perpheral blocker in Parkinson's disease

✍ Scribed by G.U. Corsini; M. Del Zompo; F. Tocco; P. Arca; G.L. Gessa

Book ID
114074858
Publisher
Elsevier Science
Year
1980
Weight
441 KB
Volume
12
Category
Article
ISSN
0031-6989

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Increased expression of dopamine recepto
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease
✍ Piero Barbanti; Giovanni Fabbrini; Alberto Ricci; Rosanna Cerbo; Elena Bronzetti πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 2 views

Dopamine D1-like and D2-like receptors on peripheral blood lymphocytes (PBL) were assayed in 50 de novo patients with idiopathic Parkinson's disease (PD), in 36 neurologic control subjects (multiple-system atrophy, n ‫ב‬ 16; essential tremor, n ‫ב‬ 10; other neurodegenerative diseases, n ‫ב‬ 10), an

Long-term tolerability and efficacy of c
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
✍ R. Inzelberg; P. Nisipeanu; M. J. Rabey; Prof. A. D. Korczyn πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 333 KB πŸ‘ 2 views

## Abstract Motor fluctuations constitute a severe complication of chronic levodopa therapy. The addition of dopamine agonists may partially alleviate these responses; however, due to the short half‐lefe of these drugs, several daily doses are required. Cabergoline is a new dopamine agonist with a